Relay Therapeutics Reports First Quarter 2023 Financial Results and Corporate Highlights
04 mai 2023 16h05 HE
|
Relay Therapeutics, Inc.
Presented initial clinical data for RLY-2608 at American Association for Cancer Research (AACR) Annual Meeting 2023 Initiated clinical trial for RLY-5836, a chemically-distinct PI3Kα pan-mutant...